Skip to main content

789 Intratumoral plasmid IL-12 expands CD8+ T cells and induces a clinically validated CXCR3 signature in triple-negative breast cancer

Publication ,  Conference
Crosby, E; Nagata, H; Telli, M; Acharya, C; Wapnir, I; Zablotsky, K; Browning, E; Hermiz, R; Svenson, L; Bannavong, D; Malloy, K; Canton, D ...
Published in: Late-breaking abstracts
November 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Late-breaking abstracts

DOI

Publication Date

November 2020

Publisher

BMJ Publishing Group Ltd

Conference Name

35th Anniversary Annual Meeting (SITC 2020)

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Crosby, E., Nagata, H., Telli, M., Acharya, C., Wapnir, I., Zablotsky, K., … Lyerly, H. (2020). 789 Intratumoral plasmid IL-12 expands CD8+ T cells and induces a clinically validated CXCR3 signature in triple-negative breast cancer. In Late-breaking abstracts. BMJ Publishing Group Ltd. https://doi.org/10.1136/jitc-2020-sitc2020.0789
Crosby, Erika, Hiroshi Nagata, Melinda Telli, Chaitanya Acharya, Irene Wapnir, Kaitlin Zablotsky, Erica Browning, et al. “789 Intratumoral plasmid IL-12 expands CD8+ T cells and induces a clinically validated CXCR3 signature in triple-negative breast cancer.” In Late-Breaking Abstracts. BMJ Publishing Group Ltd, 2020. https://doi.org/10.1136/jitc-2020-sitc2020.0789.
Crosby E, Nagata H, Telli M, Acharya C, Wapnir I, Zablotsky K, et al. 789 Intratumoral plasmid IL-12 expands CD8+ T cells and induces a clinically validated CXCR3 signature in triple-negative breast cancer. In: Late-breaking abstracts. BMJ Publishing Group Ltd; 2020.
Crosby, Erika, et al. “789 Intratumoral plasmid IL-12 expands CD8+ T cells and induces a clinically validated CXCR3 signature in triple-negative breast cancer.” Late-Breaking Abstracts, BMJ Publishing Group Ltd, 2020. Crossref, doi:10.1136/jitc-2020-sitc2020.0789.
Crosby E, Nagata H, Telli M, Acharya C, Wapnir I, Zablotsky K, Browning E, Hermiz R, Svenson L, Bannavong D, Malloy K, Canton D, Twitty C, Osada T, Lyerly H. 789 Intratumoral plasmid IL-12 expands CD8+ T cells and induces a clinically validated CXCR3 signature in triple-negative breast cancer. Late-breaking abstracts. BMJ Publishing Group Ltd; 2020.

Published In

Late-breaking abstracts

DOI

Publication Date

November 2020

Publisher

BMJ Publishing Group Ltd

Conference Name

35th Anniversary Annual Meeting (SITC 2020)

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology